Shionogi is enhancing our strengths as a drug discovery-based pharmaceutical company to create innovative products and services and to deliver value.
Shionogi conducts research and development, manufacturing, and sales activities of OTC drugs and diagnostic drugs, centering prescription drugs, in order to continuously create innovative healthcare products and services.
The characteristics of the pharmaceutical market and pharmaceutical business are posted.
Medium-term business plan, value creation process, and material issues are posted.
The main IR (Investor Relations) materials are posted.
The consolidated financial highlights from FY2016 to FY2020 are posted.
Presentation materials such as meeing sessions held each year are posted.
Shionogi has a shareholder return policy that shareholders feel growth together.
The schedule of IR events is posted.
